Corporación América Airports Reports First Quarter 2025 Results — Neutral
CAAP Business Wire — May 22, 2025LUXEMBOURG--(BUSINESS WIRE)--Corporación América Airports S.A. (NYSE: CAAP), (“CAAP” or the “Company”) one of the leading private airport operators in the world, reported today its unaudited, consolidated results for the three-month period ended March 31, 2025. Financial results are expressed in millions of U.S. dollars and are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Commencing 3Q18, the C.

e.l.f. Beauty to Webcast Fireside Chat at the dbAccess Global Consumer Conference — Neutral
ELF Business Wire — May 22, 2025OAKLAND, Calif.--(BUSINESS WIRE)--e.l.f. Beauty (NYSE: ELF) announced today that Chairman and Chief Executive Officer, Tarang Amin, will participate in a fireside chat at Deutsche Bank's dbAccess Global Consumer Conference in Paris on Thursday, June 5, 2025 at 9:15am CEST (3:15am ET). The webcast will be broadcasted live at https://investor.elfbeauty.com/stock-and-financial/events-and-presentations. For those unable to listen to the live broadcast, an archived version will be available at the s.

SAN FRANCISCO--(BUSINESS WIRE)--Elastic (NYSE: ESTC), the Search AI Company, announced that its management will present at the following conferences: Bank of America Global Technology Conference on Wednesday, June 4, 2025 at 1:20 p.m. PT / 4:20 p.m. ET Rosenblatt Technology Summit on Wednesday, June 11, 2025 at 12:00 p.m. PT / 3:00 p.m. ET A live webcast and replay of the event will be available on Elastic's Investor Relations page at ir.elastic.co. About Elastic: Elastic (NYSE: ESTC), the Sear.

Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock and Appoints Derek Chang to Board of Directors — Neutral
LBRDA Business Wire — May 22, 2025ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Broadband Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock and Appoints Derek Chang to Board of Directors.

Crown LNG Holdings Limited Discloses Receipt of NASDAQ Notice — Neutral
CGBS GlobeNewsWire — May 22, 2025LONDON, May 22, 2025 (GLOBE NEWSWIRE) -- On May 19, 2025, Crown LNG Holdings Limited (the “Company”) (NASDAQ: CGBS), received a letter (the “Letter”) from The NASDAQ Stock Market LLC (“NASDAQ”) indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the period ended December 31, 2024 (the “20-F”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with NASDAQ Listing Rule 5250(c)(1), which requires timely filing of all required financial reports with the SEC.

Red River Bancshares, Inc. Announces Private Stock Repurchase — Neutral
RRBI GlobeNewsWire — May 22, 2025ALEXANDRIA, La., May 22, 2025 (GLOBE NEWSWIRE) -- Red River Bancshares, Inc. (Nasdaq: RRBI) (the “Company”) announced today that, on May 22, 2025, the Company entered into a stock repurchase agreement with a shareholder for the repurchase by the Company of 100,000 shares of its common stock in a privately-negotiated transaction for a purchase price of $5.1 million. The purchase price reflects a discount to the 10-, 20-, and 30-day volume weighted average price on May 20, 2025. Blake Chatelain, the Company's President and Chief Executive Officer, said, “We are pleased to complete this repurchase, which shows our continued commitment …

New York, NY, May 22, 2025 (GLOBE NEWSWIRE) -- Interpublic Group (NYSE: IPG) today announced that the company's Board of Directors has declared a quarterly dividend on IPG common stock of $0.33 per share, payable on June 16, 2025, to holders of record at the close of business on June 2, 2025.

Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting — Neutral
BDRX GlobeNewsWire — May 22, 2025May 22, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announces a Notice of a General Meeting to be held at the Company's offices, 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ on 11 June 2025 at 1.00pm was posted to shareholders today. The Board of Directors is proposing four resolutions: Ordinary Resolutions 1.

ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc. will host its 2025 Investor Day on Thursday, September 4, starting at 8:00 a.m. (CT) in Eagan, MN. Christophe Beck chairman and chief executive officer, Scott Kirkland chief financial officer, and other members of the Ecolab senior leadership team will provide an in-depth review of the company's strategy, growth drivers, and financial objectives. The event will include formal presentations, Q&A sessions, a leadership luncheon, and interactive se.

Materion Appoints Melissa Fashinpaur Chief Accounting Officer — Neutral
MTRN Business Wire — May 22, 2025MAYFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--Materion Corporation (NYSE: MTRN) announced today that Melissa Fashinpaur has been appointed chief accounting officer, effective June 1, 2025. In her new role, Ms. Fashinpaur will be responsible for all accounting-related functions within the company, ensuring the completeness and accuracy of internal and external financial reporting, developing and implementing global accounting policies and procedures, maintaining a robust framework of internal control.

NYSE President and ICE Fixed Income and Data Services Chair Lynn Martin to Present at the Piper Sandler Global Exchange and Trading Conference on June 5 — Neutral
ICE Business Wire — May 22, 2025ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data, announced today that Lynn Martin, NYSE President and ICE Fixed Income and Data Services Chair, will present at the Piper Sandler Global Exchange and Trading Conference. The presentation will take place on Thursday, June 5 at 10:30 a.m. ET. The presentation will be available live and in replay via webcast and can be accessed in the investor relations and media sectio.

UNH LAWSUIT ALERT: Levi & Korsinsky Notifies UnitedHealth Group Incorporated Investors - Lead Plaintiff Deadline July 7, 2025 — Neutral
UNH Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your UnitedHealth Group Incorporated (NYSE:UNH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/unitedhealth-group-incorporated-lawsuit-submission-form?prid=149833&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq.

Xerox Updates Capital Allocation Policy Ahead of Lexmark Acquisition — Neutral
XRX Business Wire — May 22, 2025NORWALK, Conn.--(BUSINESS WIRE)--Xerox announced today that its Board of Directors approved an update to its dividend policy in anticipation of the closing of the Lexmark transaction, reducing the quarterly dividend to $0.025 per share ($0.10 per share annualized). Accordingly, Xerox announced the declaration of a quarterly dividend of $0.025 per share on Xerox Holdings Corporation Common Stock. The dividend is payable on July 31, 2025, to shareholders of record on June 30, 2025. In December 20.

Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge – Hagens Berman — Neutral
IOVA GlobeNewsWire — May 22, 2025SAN FRANCISCO, May 22, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is facing a securities class action lawsuit in the Northern District of California, alleging that the company misled investors about its growth potential and ability to capitalize on demand for its cancer treatments. The case, Farberov v. Iovance Biotherapeutics, Inc., et al., centers on statements made between May 9, 2024, and May 8, 2025, a period that includes an expansion from the initial August 2024 start date.

HOUSTON--(BUSINESS WIRE)--Stellar Bancorp, Inc. (the “Company”) (NYSE: STEL) announced today that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock payable on June 30, 2025, to the shareholders of record at the close of business on June 16, 2025. About Stellar Bancorp, Inc. Stellar Bancorp, Inc. is a bank holding company headquartered in Houston, Texas. The Company's principal banking subsidiary, Stellar Bank, provides a diversified range of commercial.

QuidelOrtho to Participate in Upcoming Investor Conferences — Neutral
QDEL Business Wire — May 22, 2025SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team will participate in two upcoming investor conferences: William Blair 45th Annual Growth Stock Conference, Wednesday, June 4, 2025 Members of QuidelOrtho's management team will participate in a presentation at 9:00 a.m. ET.

ZURICH, Switzerland--(BUSINESS WIRE)--Helena Helmersson Elected To On Board of Directors.

Lincoln National Corporation's Board of Directors Declares Quarterly Cash Dividend — Neutral
LNC Business Wire — May 22, 2025RADNOR, Pa.--(BUSINESS WIRE)--Lincoln Financial (NYSE:LNC) announced today that the board of directors of Lincoln National Corporation declared a quarterly cash dividend of $0.45 per share on the corporation's common stock. The dividend on the common stock will be payable August 1, 2025 to shareholders of record at the close of business on July 10, 2025. About Lincoln Financial Lincoln Financial helps people confidently plan for their vision of a successful financial future. As of December 31,.

Join Class Action to Recover Losses from Zenas BioPharma, Inc. (ZBIO) - Contact Levi & Korsinsky Before June 16, 2025 — Neutral
ZBIO Accesswire — May 22, 2025NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=149841&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.

NHI Stockholders Elect All Four of NHI's Director Nominees at the 2025 Annual Meeting — Neutral
NHI Accesswire — May 22, 2025MURFREESBORO, TN / ACCESS Newswire / May 22, 2025 / National Health Investors, Inc. (NYSE:NHI) ("NHI" or "the Company") announced that, based on preliminary vote results provided by the independent Inspector of Elections following the Company's 2025 Annual Meeting of Stockholders, NHI's stockholders have voted to elect all four of the Company's director nominees - Robert G. Adams, Robert W.
